期刊
CURRENT MEDICINAL CHEMISTRY
卷 18, 期 20, 页码 3028-3034出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/092986711796391697
关键词
GSK-3 inhibitors; amyotrophic lateral sclerosis (ALS); neurodegenerative diseases; motor neurons
资金
- MICINN
- ISCiii [SAF2009-13015-CO2-01, PPT-300000-2009-11, RD07-0060/0015]
- CSIC
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects motor neurons. Lately, this disease has often been related to the protein kinase called glycogen synthase kinase 3 (GSK-3), through the experimental evidence of alterations of this enzyme on ALS patients. Therefore, there have been several experimental studies using GSK-3 inhibitors, in cellular and animal models and also in clinical studies that showed the potential of the therapeutic role of these molecules. GSK-3 inhibitors might play a pivotal role in the pharmacology of ALS disease with no curative treatment nowadays. In this review we give an overview of the current research in the area, showing all the evidences of the implication of dysfunctional GSK-3 in this disease on one hand, and on the other presenting the potential role of the GSK-3 inhibitors as a future pharmacological ALS therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据